0.25Open0.25Pre Close0 Volume139 Open Interest135.00Strike Price0.00Turnover229.88%IV64.06%PremiumAug 30, 2024Expiry Date0.00Intrinsic Value100Multiplier4DDays to Expiry0.25Extrinsic Value100Contract SizeAmericanOptions Type0.0334Delta0.0036Gamma329.76Leverage Ratio-0.1463Theta0.0003Rho11.02Eff Leverage0.0067Vega
Fomo Mofo : we all saw the webinar. for a company with 18 employees id say they are doing really well. let's hope the stock gods smile upon us on Monday with some official good news
Ken Griffin Charity2 : Why not provide the source? GeoVax Expands Rights Under NIH COVID-19 License to Include Mpox and Smallpox This press release was published 19 December 2023.
Geovax has been working on a covid vaccine for the past 4 years. There is still no approved covid vaccine, much less one for mpox.